Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1976 Sep;184(3):333–341. doi: 10.1097/00000658-197609000-00011

Steroids in the treatment of clinical septic shock.

W Schumer
PMCID: PMC1344393  PMID: 786190

Abstract

A prospective (Part I) and a retrospective (Part II) study were used to determine the safety and efficacy of corticosteroids in the treatment of septic shock. In Part I, 172 consecutive patients in septic shock admitted over an 8-year period were treated with either steroid or saline: 43 received dexamethasone (DMP), 43 received methylprednisolone (MPS), and 86 received saline. The study was double-blind and randomized, and the three groups were compared for age, severity of shock, presence of underlying disease, and year of study. In the 86 saline-treated patients, the mortality rate was 38.4% (33/86); in the steroid-treated patients, it was 10.4% (9/86). With MPS the mortality rate was 11.6% (5/43), and with DMP it was 9.3% (4/43). Thus, overall mortality was significantly less in the steroid-treated group than in the control group. Further, there was no significant difference in mortality rate between the DMP- and the MPS-treated patients. In Part II, 328 patients were studied retrospectively. One-hundred sixty were treated without steroid, and 168 were treated with either DMP or MPS. Again, the two groups of patients were compared for severity of shock, underlying disease, age, and year of study. Mortality among patients treated without steroid was 42.5% (68/160) and among patients treated with steroid was 14% (24/168); there was no significant difference in mortality rate between DMP- and MPS-treated patients. In Parts I and II combined, complications occurred in 6% of steroid-treated patients with no significant difference between DMP- and MPS-treated groups.

Full text

PDF
333

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DuPont H. L., Spink W. W. Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) 1969 Jul;48(4):307–332. doi: 10.1097/00005792-196907000-00003. [DOI] [PubMed] [Google Scholar]
  2. From A. H., Gewurz H., Gruninger R. P., Pickering R. J., Spink W. W. Complement in endotoxin shock: effect of complement depletion on the early hypotensive phase. Infect Immun. 1970 Jul;2(1):38–41. doi: 10.1128/iai.2.1.38-41.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. LILLEHEI R. C., LONGERBEAM J. K., BLOCH J. H. PHYSIOLOGY AND THERAPY OF BACTEREMIC SHOCK. EXPERIMENTAL AND CLINICAL OBSERVATIONS. Am J Cardiol. 1963 Nov;12:599–613. doi: 10.1016/0002-9149(63)90244-3. [DOI] [PubMed] [Google Scholar]
  4. LaNoue K. F., Mason A. D., Jr, Daniels J. P. The impairment of glucogenesis by gram negative infection. Metabolism. 1968 Jul;17(7):606–611. doi: 10.1016/0026-0495(68)90019-x. [DOI] [PubMed] [Google Scholar]
  5. Neely W. A., Berry D. W., Rushton F. W., Hardy J. D. Septic shock: clinical, physiological, and pathological survey of 244 patients. Ann Surg. 1971 May;173(5):657–666. doi: 10.1097/00000658-197105000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Pitcairn M., Schuler J., Erve P. R., Holtzman S., Schumer W. Glucocorticoid and antibiotic effect on experimental gram-negative bacteremic shock. Arch Surg. 1975 Aug;110(8):1012–1015. doi: 10.1001/archsurg.1975.01360140156030. [DOI] [PubMed] [Google Scholar]
  7. ROSENBERG J. C., LILLEHEI R. C., LONGERBEAM J., ZIMMERMANN B. Studies on hemorrhagic and endotoxin shock in relation to vasomotor changes and endogenous circulating epinephrine, norepinephrine and serotonin. Ann Surg. 1961 Oct;154:611–628. doi: 10.1097/00000658-196110000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Schuler J. J., Erve P. R., Schumer W. Glucocorticoid effect on hepatic carbohydrate metabolism in the endotoxin-shocked monkey. Ann Surg. 1976 Apr;183(4):345–354. doi: 10.1097/00000658-197604000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Seneca H., Grant J. P., Jr Glucocorticoid therapy in sepsis/shock caused by gram-negative microorganisms. J Am Geriatr Soc. 1975 Nov;23(11):493–502. doi: 10.1111/j.1532-5415.1975.tb00895.x. [DOI] [PubMed] [Google Scholar]
  10. Weitzman S., Berger S. Clinical trial design in studies of corticosteroids for bacterial infections. Ann Intern Med. 1974 Jul;81(1):36–42. doi: 10.7326/0003-4819-81-1-36. [DOI] [PubMed] [Google Scholar]
  11. Williamson J. R., Refino C., LaNoue K. Effects of E. coli lipopolysaccharide B treatment of rats on gluconeogenesis. In: Energy metabolism in trauma. Ciba Found Symp. 1970:145–154. doi: 10.1002/9780470719770.ch8. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES